X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
33
PharmaCompass offers a list of Eltrombopag API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Eltrombopag manufacturer or Eltrombopag supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Eltrombopag manufacturer or Eltrombopag supplier.
PharmaCompass also assists you with knowing the Eltrombopag API Price utilized in the formulation of products. Eltrombopag API Price is not always fixed or binding as the Eltrombopag Price is obtained through a variety of data sources. The Eltrombopag Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Revolade manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Revolade, including repackagers and relabelers. The FDA regulates Revolade manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Revolade API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Revolade manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Revolade supplier is an individual or a company that provides Revolade active pharmaceutical ingredient (API) or Revolade finished formulations upon request. The Revolade suppliers may include Revolade API manufacturers, exporters, distributors and traders.
click here to find a list of Revolade suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Revolade DMF (Drug Master File) is a document detailing the whole manufacturing process of Revolade active pharmaceutical ingredient (API) in detail. Different forms of Revolade DMFs exist exist since differing nations have different regulations, such as Revolade USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Revolade DMF submitted to regulatory agencies in the US is known as a USDMF. Revolade USDMF includes data on Revolade's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Revolade USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Revolade suppliers with USDMF on PharmaCompass.
A Revolade written confirmation (Revolade WC) is an official document issued by a regulatory agency to a Revolade manufacturer, verifying that the manufacturing facility of a Revolade active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Revolade APIs or Revolade finished pharmaceutical products to another nation, regulatory agencies frequently require a Revolade WC (written confirmation) as part of the regulatory process.
click here to find a list of Revolade suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Revolade as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Revolade API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Revolade as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Revolade and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Revolade NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Revolade suppliers with NDC on PharmaCompass.
Revolade Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Revolade GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Revolade GMP manufacturer or Revolade GMP API supplier for your needs.
A Revolade CoA (Certificate of Analysis) is a formal document that attests to Revolade's compliance with Revolade specifications and serves as a tool for batch-level quality control.
Revolade CoA mostly includes findings from lab analyses of a specific batch. For each Revolade CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Revolade may be tested according to a variety of international standards, such as European Pharmacopoeia (Revolade EP), Revolade JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Revolade USP).
Market Place
